Loading…
Radiation-induced dermatitis among breast cancer patients undergoing adjuvant radiotherapy in Ghana
The aim of the study was to investigate radiation-induced epidermal desquamation among breast cancer patients undergoing radiotherapy with 6MV linac and Co-60 teletherapy units. Quantitative data was collected using self-administered closed ended questionnaires addressing the desquamation in relatio...
Saved in:
Published in: | Translational oncology 2024-08, Vol.46, p.102028, Article 102028 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c363t-e9ebcde7e9d39bb1509e1089b37553fbfc4dbd4aa18a5e1426e2ee6a98fd382a3 |
container_end_page | |
container_issue | |
container_start_page | 102028 |
container_title | Translational oncology |
container_volume | 46 |
creator | Kyei, K.A. Anim-Sampong, S. Akoe, E.A. Daniels, J. Obeng-Mensah, T. Antwi, W.K. Ainuson-Quampah, J. |
description | The aim of the study was to investigate radiation-induced epidermal desquamation among breast cancer patients undergoing radiotherapy with 6MV linac and Co-60 teletherapy units.
Quantitative data was collected using self-administered closed ended questionnaires addressing the desquamation in relation to some patient-and treatment-related factors. The Radiation Therapy Oncology Group (RTOG) criteria for acute skin toxicity was used to grade the toxicity. Chi square and logistic regression analyses were respectively used to test statistical significance and evaluate the effects of the various factors on radiation induced epidermal desquamation
Majority of the participants had high BMIs (overweight: 39.5 %; obese: 50 %). Patients with BMI ≥ 25 kg/m2 presented with wet desquamation (RTOG grade 2). A chi-square analysis showed a significant difference (p = 0.02) between BMI and severity of desquamation. There was no significant difference between type of treatment machine and cumulative incidence dose of desquamation (p= 0.251). The logistic regression analysis showed that patients who had undergone mastectomy (OR = 0.562) were less likely to develop wet desquamation (RTOG grade 2) on the Co-60 machine within the 20–30 Gy threshold (OR=0.981) compared to those on the linear accelerator. Patients with lower BMI (OR = 0.412,[ < 25 vs ≥30]; OR = 0.286, [25–29.9 vs ≥30]) were also less likely to develop wet desquamation compared to those with higher BMI.
Radiation-induced epidermal desquamation is a common side effect of breast cancer patients undergoing radiotherapy. BMI has an effect on the severity of desquamation experienced during breast irradiation. |
doi_str_mv | 10.1016/j.tranon.2024.102028 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d53f2ccca1bc4d62bddff1c2c1cc1472</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1936523324001554</els_id><doaj_id>oai_doaj_org_article_d53f2ccca1bc4d62bddff1c2c1cc1472</doaj_id><sourcerecordid>3070792771</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-e9ebcde7e9d39bb1509e1089b37553fbfc4dbd4aa18a5e1426e2ee6a98fd382a3</originalsourceid><addsrcrecordid>eNp9kU1vFDEMhkcIREvhHyA0Ry6z5GM-LyBUQalUCQnBOXIcz25GM8mSZFbqvydlStVeODmyXz92_BbFW852nPH2w7RLAZx3O8FEnVM59M-Kcz7ItmqElM8fvc-KVzFOjLV8EOJlcSb7vuV9U58X-AOMhWS9q6wzK5IpDYUlZ5KNJSze7UsdCGIqERxSKI-5Ri7FcnVZufc2K8BM6wlcKkOm-XSgAMfb0rry6gAOXhcvRpgjvbmPF8Wvr19-Xn6rbr5fXV9-vqlQtjJVNJBGQx0NRg5a84YNxFk_aNk1jRz1iLXRpgbgPTTEa9GSIGph6EcjewHyorjeuMbDpI7BLhBulQer_iZ82CsIyeJMymSgQETgOlNboY0ZR44COSKvO5FZnzbWcdULGcw_DjA_gT6tOHtQe39SnAs2tFJmwvt7QvC_V4pJLTYizTM48mtUknWsG0TX8SytNykGH2Og8WEOZ-rObDWpzWx1Z7bazM5t7x7v-ND0z90s-LgJKF_9ZCmoiNm7bLINhCmfxf5_wh_HfsF_</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3070792771</pqid></control><display><type>article</type><title>Radiation-induced dermatitis among breast cancer patients undergoing adjuvant radiotherapy in Ghana</title><source>ScienceDirect</source><source>Open Access: PubMed Central</source><creator>Kyei, K.A. ; Anim-Sampong, S. ; Akoe, E.A. ; Daniels, J. ; Obeng-Mensah, T. ; Antwi, W.K. ; Ainuson-Quampah, J.</creator><creatorcontrib>Kyei, K.A. ; Anim-Sampong, S. ; Akoe, E.A. ; Daniels, J. ; Obeng-Mensah, T. ; Antwi, W.K. ; Ainuson-Quampah, J.</creatorcontrib><description>The aim of the study was to investigate radiation-induced epidermal desquamation among breast cancer patients undergoing radiotherapy with 6MV linac and Co-60 teletherapy units.
Quantitative data was collected using self-administered closed ended questionnaires addressing the desquamation in relation to some patient-and treatment-related factors. The Radiation Therapy Oncology Group (RTOG) criteria for acute skin toxicity was used to grade the toxicity. Chi square and logistic regression analyses were respectively used to test statistical significance and evaluate the effects of the various factors on radiation induced epidermal desquamation
Majority of the participants had high BMIs (overweight: 39.5 %; obese: 50 %). Patients with BMI ≥ 25 kg/m2 presented with wet desquamation (RTOG grade 2). A chi-square analysis showed a significant difference (p = 0.02) between BMI and severity of desquamation. There was no significant difference between type of treatment machine and cumulative incidence dose of desquamation (p= 0.251). The logistic regression analysis showed that patients who had undergone mastectomy (OR = 0.562) were less likely to develop wet desquamation (RTOG grade 2) on the Co-60 machine within the 20–30 Gy threshold (OR=0.981) compared to those on the linear accelerator. Patients with lower BMI (OR = 0.412,[ < 25 vs ≥30]; OR = 0.286, [25–29.9 vs ≥30]) were also less likely to develop wet desquamation compared to those with higher BMI.
Radiation-induced epidermal desquamation is a common side effect of breast cancer patients undergoing radiotherapy. BMI has an effect on the severity of desquamation experienced during breast irradiation.</description><identifier>ISSN: 1936-5233</identifier><identifier>EISSN: 1936-5233</identifier><identifier>DOI: 10.1016/j.tranon.2024.102028</identifier><identifier>PMID: 38861854</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>BMI ; Breast cancer ; Desquamation ; Hypofractionation ; Toxicity</subject><ispartof>Translational oncology, 2024-08, Vol.46, p.102028, Article 102028</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier Inc.</rights><rights>2024 Published by Elsevier Inc. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c363t-e9ebcde7e9d39bb1509e1089b37553fbfc4dbd4aa18a5e1426e2ee6a98fd382a3</cites><orcidid>0000-0003-3485-5368</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11209633/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1936523324001554$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38861854$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kyei, K.A.</creatorcontrib><creatorcontrib>Anim-Sampong, S.</creatorcontrib><creatorcontrib>Akoe, E.A.</creatorcontrib><creatorcontrib>Daniels, J.</creatorcontrib><creatorcontrib>Obeng-Mensah, T.</creatorcontrib><creatorcontrib>Antwi, W.K.</creatorcontrib><creatorcontrib>Ainuson-Quampah, J.</creatorcontrib><title>Radiation-induced dermatitis among breast cancer patients undergoing adjuvant radiotherapy in Ghana</title><title>Translational oncology</title><addtitle>Transl Oncol</addtitle><description>The aim of the study was to investigate radiation-induced epidermal desquamation among breast cancer patients undergoing radiotherapy with 6MV linac and Co-60 teletherapy units.
Quantitative data was collected using self-administered closed ended questionnaires addressing the desquamation in relation to some patient-and treatment-related factors. The Radiation Therapy Oncology Group (RTOG) criteria for acute skin toxicity was used to grade the toxicity. Chi square and logistic regression analyses were respectively used to test statistical significance and evaluate the effects of the various factors on radiation induced epidermal desquamation
Majority of the participants had high BMIs (overweight: 39.5 %; obese: 50 %). Patients with BMI ≥ 25 kg/m2 presented with wet desquamation (RTOG grade 2). A chi-square analysis showed a significant difference (p = 0.02) between BMI and severity of desquamation. There was no significant difference between type of treatment machine and cumulative incidence dose of desquamation (p= 0.251). The logistic regression analysis showed that patients who had undergone mastectomy (OR = 0.562) were less likely to develop wet desquamation (RTOG grade 2) on the Co-60 machine within the 20–30 Gy threshold (OR=0.981) compared to those on the linear accelerator. Patients with lower BMI (OR = 0.412,[ < 25 vs ≥30]; OR = 0.286, [25–29.9 vs ≥30]) were also less likely to develop wet desquamation compared to those with higher BMI.
Radiation-induced epidermal desquamation is a common side effect of breast cancer patients undergoing radiotherapy. BMI has an effect on the severity of desquamation experienced during breast irradiation.</description><subject>BMI</subject><subject>Breast cancer</subject><subject>Desquamation</subject><subject>Hypofractionation</subject><subject>Toxicity</subject><issn>1936-5233</issn><issn>1936-5233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kU1vFDEMhkcIREvhHyA0Ry6z5GM-LyBUQalUCQnBOXIcz25GM8mSZFbqvydlStVeODmyXz92_BbFW852nPH2w7RLAZx3O8FEnVM59M-Kcz7ItmqElM8fvc-KVzFOjLV8EOJlcSb7vuV9U58X-AOMhWS9q6wzK5IpDYUlZ5KNJSze7UsdCGIqERxSKI-5Ri7FcnVZufc2K8BM6wlcKkOm-XSgAMfb0rry6gAOXhcvRpgjvbmPF8Wvr19-Xn6rbr5fXV9-vqlQtjJVNJBGQx0NRg5a84YNxFk_aNk1jRz1iLXRpgbgPTTEa9GSIGph6EcjewHyorjeuMbDpI7BLhBulQer_iZ82CsIyeJMymSgQETgOlNboY0ZR44COSKvO5FZnzbWcdULGcw_DjA_gT6tOHtQe39SnAs2tFJmwvt7QvC_V4pJLTYizTM48mtUknWsG0TX8SytNykGH2Og8WEOZ-rObDWpzWx1Z7bazM5t7x7v-ND0z90s-LgJKF_9ZCmoiNm7bLINhCmfxf5_wh_HfsF_</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Kyei, K.A.</creator><creator>Anim-Sampong, S.</creator><creator>Akoe, E.A.</creator><creator>Daniels, J.</creator><creator>Obeng-Mensah, T.</creator><creator>Antwi, W.K.</creator><creator>Ainuson-Quampah, J.</creator><general>Elsevier Inc</general><general>Neoplasia Press</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3485-5368</orcidid></search><sort><creationdate>20240801</creationdate><title>Radiation-induced dermatitis among breast cancer patients undergoing adjuvant radiotherapy in Ghana</title><author>Kyei, K.A. ; Anim-Sampong, S. ; Akoe, E.A. ; Daniels, J. ; Obeng-Mensah, T. ; Antwi, W.K. ; Ainuson-Quampah, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-e9ebcde7e9d39bb1509e1089b37553fbfc4dbd4aa18a5e1426e2ee6a98fd382a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>BMI</topic><topic>Breast cancer</topic><topic>Desquamation</topic><topic>Hypofractionation</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kyei, K.A.</creatorcontrib><creatorcontrib>Anim-Sampong, S.</creatorcontrib><creatorcontrib>Akoe, E.A.</creatorcontrib><creatorcontrib>Daniels, J.</creatorcontrib><creatorcontrib>Obeng-Mensah, T.</creatorcontrib><creatorcontrib>Antwi, W.K.</creatorcontrib><creatorcontrib>Ainuson-Quampah, J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Translational oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kyei, K.A.</au><au>Anim-Sampong, S.</au><au>Akoe, E.A.</au><au>Daniels, J.</au><au>Obeng-Mensah, T.</au><au>Antwi, W.K.</au><au>Ainuson-Quampah, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiation-induced dermatitis among breast cancer patients undergoing adjuvant radiotherapy in Ghana</atitle><jtitle>Translational oncology</jtitle><addtitle>Transl Oncol</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>46</volume><spage>102028</spage><pages>102028-</pages><artnum>102028</artnum><issn>1936-5233</issn><eissn>1936-5233</eissn><abstract>The aim of the study was to investigate radiation-induced epidermal desquamation among breast cancer patients undergoing radiotherapy with 6MV linac and Co-60 teletherapy units.
Quantitative data was collected using self-administered closed ended questionnaires addressing the desquamation in relation to some patient-and treatment-related factors. The Radiation Therapy Oncology Group (RTOG) criteria for acute skin toxicity was used to grade the toxicity. Chi square and logistic regression analyses were respectively used to test statistical significance and evaluate the effects of the various factors on radiation induced epidermal desquamation
Majority of the participants had high BMIs (overweight: 39.5 %; obese: 50 %). Patients with BMI ≥ 25 kg/m2 presented with wet desquamation (RTOG grade 2). A chi-square analysis showed a significant difference (p = 0.02) between BMI and severity of desquamation. There was no significant difference between type of treatment machine and cumulative incidence dose of desquamation (p= 0.251). The logistic regression analysis showed that patients who had undergone mastectomy (OR = 0.562) were less likely to develop wet desquamation (RTOG grade 2) on the Co-60 machine within the 20–30 Gy threshold (OR=0.981) compared to those on the linear accelerator. Patients with lower BMI (OR = 0.412,[ < 25 vs ≥30]; OR = 0.286, [25–29.9 vs ≥30]) were also less likely to develop wet desquamation compared to those with higher BMI.
Radiation-induced epidermal desquamation is a common side effect of breast cancer patients undergoing radiotherapy. BMI has an effect on the severity of desquamation experienced during breast irradiation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38861854</pmid><doi>10.1016/j.tranon.2024.102028</doi><orcidid>https://orcid.org/0000-0003-3485-5368</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1936-5233 |
ispartof | Translational oncology, 2024-08, Vol.46, p.102028, Article 102028 |
issn | 1936-5233 1936-5233 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_d53f2ccca1bc4d62bddff1c2c1cc1472 |
source | ScienceDirect; Open Access: PubMed Central |
subjects | BMI Breast cancer Desquamation Hypofractionation Toxicity |
title | Radiation-induced dermatitis among breast cancer patients undergoing adjuvant radiotherapy in Ghana |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T23%3A14%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiation-induced%20dermatitis%20among%20breast%20cancer%20patients%20undergoing%20adjuvant%20radiotherapy%20in%20Ghana&rft.jtitle=Translational%20oncology&rft.au=Kyei,%20K.A.&rft.date=2024-08-01&rft.volume=46&rft.spage=102028&rft.pages=102028-&rft.artnum=102028&rft.issn=1936-5233&rft.eissn=1936-5233&rft_id=info:doi/10.1016/j.tranon.2024.102028&rft_dat=%3Cproquest_doaj_%3E3070792771%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c363t-e9ebcde7e9d39bb1509e1089b37553fbfc4dbd4aa18a5e1426e2ee6a98fd382a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3070792771&rft_id=info:pmid/38861854&rfr_iscdi=true |